Sphingosine-1-phosphate decreases melanin synthesis via microphthalmia-associated transcription factor...

Area of Science:

• Cell biology
• Biochemistry
• Dermatology

Background:

• Sphingosine-1-phosphate (S1P) has been previously shown to reduce melanin synthesis.
• The precise molecular mechanisms underlying S1P-mediated melanogenesis regulation remain incompletely understood.

Purpose of the Study:

• To investigate the role of S1P receptor-mediated signaling pathways, specifically extracellular signal-regulated kinase (ERK) activation and microphthalmia-associated transcription factor (MITF) phosphorylation, in the regulation of melanin synthesis.
• To elucidate the specific S1P receptor involved in these processes.

Main Methods:

• Electron and confocal microscopy were employed to study cellular changes.
• Reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis were used to assess gene and protein expression and activation.
• Experiments utilized specific receptor antagonists and pertussis toxin to probe receptor involvement.

Main Results:

• S1P induced phosphorylation of MITF at Ser73, causing a mobility shift, and activated 90 kDa ribosomal S6 kinase-1 (RSK-1).
• PD98059 inhibited S1P-induced MITF mobility shift and RSK-1 activation, indicating the involvement of the ERK pathway.
• Pertussis toxin abolished S1P's hypopigmentary effects and ERK activation, confirming receptor-mediated signaling. The S1P(3) receptor was identified as the primary mediator of S1P-induced ERK activation and hypopigmentation.
• Dual phosphorylation of MITF at Ser73 and Ser409 was found to be essential for MITF degradation.

Conclusions:

• S1P reduces melanin synthesis through activation of the S1P(3) receptor.
• This receptor-mediated signaling involves the activation of ERK and RSK-1 pathways.
• Subsequent dual phosphorylation and degradation of MITF are critical steps in the hypopigmentary effect of S1P.